Bryan Johnson’s Big Mistake with CJC‐1295 DAC

Affiliate Disclosure: This newsletter contains affiliate links. When you purchase through these links using code PROBIO15, I may earn a commission at no additional cost to you. I only recommend vendors I personally use and trust.

What Bryan Actually Did

In mid‑April, Bryan shared that he was adding a GH axis experiment on top of his existing protocol. The core idea:x+1

• Use CJC‑1295 (a GHRH agonist) to drive endogenous GH and IGF‑1 for “growth and repair.”linkedin+1

• Combine it with tirzepatide, a GLP‑1/GIP agonist he was already using for metabolic optimization.linkedin

He explicitly acknowledged the trade‑offs up front:

• “CJC‑1295 (a GHRH agonist that drives my own GH and IGF‑1): growth and repair, but can blunt my glucose control and cause insulin resistance.”x+1

• Tirzepatide is insulin‑sensitizing but can disrupt sleep and raise resting heart rate.linkedin

His hypothesis was elegant on paper: opposite vectors on autonomic tone and glucose where “the side effects cancel but the benefits don’t.”linkedin

Two CJC‑1295 options were on the table:

• CJC‑1295 with DAC: long‑acting, weekly injection, extended half‑life, used in clinical trials.

• CJC‑1295 no‑DAC + Ipamorelin: short‑acting, nightly pre‑bed injections, clears quickly, more flexible.facebook+1

Despite knowing that CJC‑1295 can worsen insulin resistance and that DAC peptides are long acting, he chose to start with the DAC version, with a ramped protocol:x+1

• Week 1: 1.2 mg CJC‑1295 DAC

• Week 2: 2.4 mg CJC‑1295 DAC (or pivot to no‑DAC + Ipamorelin if side‑effects demanded)

• Weeks 3–4: 2.4 mg CJC‑1295 DAC weekly + 0.25 mg tirzepatide twice weekly

He said he would monitor sleep, glucose, and autonomic metrics closely and adjust as needed.linkedin

The problem: with DAC, if you misjudge tolerability, you don’t get to “just stop tomorrow.”

The Field Report: Sleep Wrecked in Two Nights

It didn’t take long for the downside to show up in his own data.

In a “Field report: night 2 on peptide CJC‑1295 DAC,” he wrote:posts.bryanjohnson+1

• “My sleep is wrecked.”

• “Two nights in and I feel like I crossed eight time zones. Minus the flight.”

His sensors backed up the subjective crash:posts.bryanjohnson

• WHOOP: REM sleep down about 40% from his 2‑week baseline, deep sleep held, disturbances up.

• 8 Sleep data showed inverted patterns and more fragmentation.posts.bryanjohnson

He then walked through why this might be happening, referencing one of the few trials that looked at sleep architecture:

• The study showed CJC‑1295 DAC preserved nocturnal GH pulses but raised basal GH ~7.5‑fold.x

• GH pulses drive slow‑wave sleep; elevating the baseline without respecting the pulsatility can scramble normal sleep gating.x

• Elevated IGF‑1 feeds back on hypothalamic GHRH and talks to the HPA axis, potentially scrambling cortisol rhythm and circadian timing.x

His phrase for how this feels: “Jet lag, endogenously generated.”x

The plan he shared publicly was to track a week, compare post‑CJC to baseline, and if sleep remained disrupted, “abort or pivot to no‑DAC + ipamorelin pre‑bed.”x

In other words: his emergency exit plan was the protocol he probably should have used from the start.

CJC‑1295 DAC vs No DAC: Why Duration Matters

To understand why this experiment bit him so fast, you have to understand the pharmacology differences between CJC‑1295 DAC and no‑DAC.

CJC‑1295 with DAC

• DAC stands for “Drug Affinity Complex,” a modification that binds the peptide to albumin and massively extends its half‑life.behemothlabz+2

• In animal and human research, a single CJC‑1295 DAC dose can:bc9+1

  • Elevate GH for 5–8 days.

  • Elevate IGF‑1 for 9–11 days.

• One human study he referenced showed nocturnal GH pulses preserved but basal GH raised 7.5x – a “raised floor” effect.x

Practically: you get a sustained, tonic GH/IGF‑1 elevation for an entire week from one injection. If your body doesn’t like it, you are married to that mistake for days.

Commonly reported side‑effects in research and clinic settings include:revolutionhealth+2

• Water retention, flushing, and injection site reactions.

• Headaches, blood pressure changes, and sometimes insomnia or sleep disruption.

• Worsening insulin resistance and impaired glucose tolerance, especially at higher or repeated doses.

CJC‑1295 No DAC (Mod GRF 1‑29)

CJC‑1295 without DAC is often referred to as Mod GRF (1‑29), a more stable analog of the original GHRH fragment without the albumin‑binding complex.uksarms+2

Key differences:behemothlabz+3

• Half‑life: roughly 30 minutes to ~2 hours, depending on the source and model.

• It acts as a pulse amplifier, enhancing natural GH pulses rather than plastering the system with a sustained elevation.

• It’s typically dosed multiple times per day or once pre‑bed, often combined with a GHRP like Ipamorelin to support physiologic, pulsatile GH release.revolutionhealth+1

Practically, that means:

• If you overshoot the dose or your sleep goes sideways, the experiment clears within hours, not days.

• You can titrate slowly, adjust timing, and abort quickly—exactly how Bryan normally designs his interventions.

Even Bryan’s own team seemed to recognize this. In a related post, he shared guidance from his clinical advisors that essentially said: start with CJC without DAC first, because it clears faster if you get flushing or cortisol spikes that elevate heart rate.facebook

He did the opposite.

Where the Blueprint Logic Broke

Viewed through a “Blueprint” lens, there are three big missteps here that your readers can learn from.

1. Choosing the least reversible tool first

Bryan’s public philosophy is all about minimal effective dose, tiny perturbations, and rapid course‑correction based on data. Yet with CJC‑1295 he picked the version that:mitohealth+1

• Locks in elevated GH and IGF‑1 for a week or more per injection.

• Is known to carry insulin resistance risk and potential autonomic disruption.

• Can’t be turned off once you realize your REM is getting crushed.behemothlabz+3

Short‑acting no‑DAC CJC plus Ipamorelin would have aligned perfectly with his usual playbook: small nightly nudge, immediate feedback via sleep and glucose metrics, easy to stop if things go sideways.

2. Over‑fitting the model, under‑estimating biology

His stated bet was that tirzepatide’s insulin‑sensitizing, weight loss, and metabolic effects would offset CJC‑1295’s tendency to worsen insulin resistance, while CJC‑1295’s slow‑wave sleep benefits would offset tirzepatide’s sleep disruption.youtube+2

On a whiteboard, those vectors line up neatly. In an actual human, especially one already running at an elite level of metabolic health and sleep, layering a long‑acting GH secretagogue on a GLP‑1/GIP agonist is asking for emergent behavior:

• Cortisol rhythm shifts.

• REM suppression and fragmented sleep.

• Strange interactions in appetite, glucose, and autonomic tone.

His own data (REM down ~40%, “eight time zones without the flight”) are a clear example of biology refusing to conform to a tidy optimization model.posts.bryanjohnson+1

3. Ignoring his own history with GH‑axis interventions

This is not his first rodeo.

Back in 2023, Bryan publicly discontinued pharmacologic HGH therapy after ~110 days due to side‑effects: symptoms suggestive of raised intracranial pressure, a 15% HRV drop, headaches, and increased blood glucose. That experiment already told him his system is sensitive to GH/IGF‑1 manipulation.linkedin

Knowing that, choosing the longest‑acting GH‑axis experiment first, at mg‑level doses, looks less like bold innovation and more like failing to integrate your own N=1 history.

Check out Blolongevity Labs 30% off Sale till the end of the month

Modern life is inflammatory.

Chronic stress. Environmental toxins. Low-grade inflammation that quietly chips away at energy, focus, and long-term health.

BrocElite Plus delivers stabilized sulforaphane, one of the most researched plant compounds for cellular defense, detox support, and neuroprotection.

Sulforaphane activates your body’s internal antioxidant systems. It supports inflammation control. It strengthens detox pathways at the cellular level.

Coaching Packages Updated

Project Biohacking Resources

Some links may be affiliate links; I may earn a small commission at no extra cost to you. I only recommend vendors I use and trust, Biolongevity Labs!

Quick links to Vetted Sources & Discount Codes

👇🏻15% - 20% off Peptide Sites Using PROBIO15 Coupon Code 👇🏻

Biolongevity Labs | Limitless Biotech | Rejuvatide Peptides | CanLabs Intl  

Ascension Peptides | Peptidology

👇🏻Supplements Affiliates👇🏻

👇🏻Lab Affiliatess👇🏻

 Guides

🔚 Outro & Final Thoughts

What He Should Have Done: A Better First Step

So if we rewind the tape, what would a more Blueprint‑compatible protocol have looked like?

For an already lean, metabolically optimized, sleep‑obsessed individual:

1. Start with CJC‑1295 no‑DAC + Ipamorelin, pre‑bed.

   • Use a conservative starting dose, once nightly, specifically targeting physiological‑like pulses of GH during the natural nocturnal window.bc9+1

   • Watch WHOOP/Ouraring/8 Sleep for changes in deep sleep, REM, total sleep time, and disturbances over 1–2 weeks before stacking anything else.

2. Keep tirzepatide stable or de‑risked.

   • Either hold tirzepatide constant during the first GH‑axis experiment or temporarily pause it to isolate variables.

   • Don’t try to “cancel out” one drug’s side‑effects with another’s; test one perturbation at a time.

3. Define hard abort criteria up front.

   • For someone who has publicly stated that irregular sleep is as harmful as insufficient sleep, a >20% hit to REM or sustained fragmentation should be a hard stop, not a “let’s see where this goes.”economictimes+1

   • With no‑DAC CJC, that’s easy: you simply don’t inject tonight.

4. Only then consider a DAC trial, if at all.

   • If he truly wanted to compare “trial‑pure” CJC‑1295 DAC versus daily short‑acting pulses, he could have run no‑DAC first, mapped the response curve, then moved to a very low‑dose DAC trial with crystal‑clear stop conditions.

That path would have preserved his sleep, respected his own GH sensitivity history, and still produced interesting data for the community.

Until next time, stay ahead of your age!
– Jeff
Founder, Project Biohacking